Some People Might Need To Delay Their COVID19 Vaccination Under Certain Conditions

Kathleen Kinder
Kathleen Kinder

Updated · Dec 28, 2020

SHARE:

News.Market.us is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more.
close
Advertiser Disclosure

At Market.us News, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us News. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Healthcare workers and government officials in the US are being inoculated with the COVID19 vaccine at present. Many people are frantically waiting for their turn. As per the data, general people will start getting the vaccine shots somewhere in April or May next year. It might look like a long time for many people, however, there are certain conditions that might postpone people’s COVID19 vaccination even further. The US Center for Disease Control and Prevention (CDC) has said that some people under certain conditions might have to delay their immunization. The CDC has made it clear that the vaccine will be given to those people, who have been diagnosed with the disease. However, if someone is suffering from a COVID19 infection at that time of planned immunization, the CDC will ask them to stay in quarantine and wait for infection and symptoms to subside. The officials from the CDC have said that vaccination of those people with SARS-CoV-2 infection will be delayed until they fully recover from the severe infection and if they meet the criteria of discontinuing quarantine. People will have to wait for their second dose after getting the first dose.

The COVID19 vaccine needs two separate doses in the gap of 21 to 28 days. Experts have said that the vaccine is only 91 percent effective after the first dose, some people may contract the virus before getting the second dose. If some people are diagnosed with COVID19 infection in between the first dose and the second dose, the CDC will ask them to postpone their next vaccination. As there is no suggested minimum gap between infection and immunization, evidence shows that reoccurrence of infection is not common within 90 days after the initial infection. People who have been diagnosed with severe COVID19 infection might need to delay their vaccination until the 90-day period is over. The health agency has issued a series of guidelines for people with a history of allergic reactions. Health officials have said that people who have gone through only mild reactions are fine but people who have a history of anaphylaxis need to be counseled about the severe allergic reaction after vaccination.

The CDC has said that people who have suffered severe allergic reactions to any of the components in either vaccine should not get a shot. The officials have said that people, who have any anaphylactic symptoms after getting the first dose of the vaccine, should not get the second dose. Health experts have not been able to develop a COVID19 vaccine for children and young adults below 16 years of age. Anyone who is above 16 years of age can get the Pfizer vaccine. However, the Moderna vaccine has been approved for people in the age range of 18 years and above. Pfizer has started testing its vaccine on children as young as 12 years in October. Moderna has declared that it is going to test its vaccine on children in the age group of 12 to 17 years as well.

SHARE:
Kathleen Kinder

Kathleen Kinder

With over 4 years of experience in the research industry, Kathleen is generally engrossed in market consulting projects, catering primarily to domains such as ICT, Health & Pharma, and packaging. She is highly proficient in managing both B2C and B2B projects, with an emphasis on consumer preference analysis, key executive interviews, etc. When Kathleen isn’t deconstructing market performance trajectories, she can be found hanging out with her pet cat ‘Sniffles’.